Cargando…

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

BACKGROUND: Colorectal cancer (CRC) remains one of the major cancer types and cancer related death worldwide. Sensitive, non-invasive biomarkers that can facilitate disease detection, staging and prediction of therapeutic outcome are highly desirable to improve survival rate and help to determine op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Hanyin, Zhang, Lina, Cogdell, David E., Zheng, Hong, Schetter, Aaron J., Nykter, Matti, Harris, Curtis C., Chen, Kexin, Hamilton, Stanley R., Zhang, Wei
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060165/ https://www.ncbi.nlm.nih.gov/pubmed/21445232 http://dx.doi.org/10.1371/journal.pone.0017745

Ejemplares similares

Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
por: Hiyoshi, Yukiharu, et al.
Publicado: (2015)

Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer
por: Yang, Ganghua, et al.
Publicado: (2022)

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer
por: Taavitsainen, Sinja, et al.
Publicado: (2019)

Cyclophilin B overexpression predicts a poor prognosis and activates metastatic pathways in colon cancer
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
por: Yan, Shushan, et al.
Publicado: (2017)

Low C6orf141 Expression is Significantly Associated with a Poor Prognosis in Patients with Oral Cancer
por: Yang, Cheng-Mei, et al.
Publicado: (2019)

MicroRNA-183 and microRNA-141 are potential risk factors for poor prognosis in patients with nasopharyngeal carcinoma
por: Lian, Junsheng, et al.
Publicado: (2019)

Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer
por: Fitriawan, Akbar Satria, et al.
Publicado: (2020)

Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
por: Zedan, A. H., et al.
Publicado: (2020)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

Effects of Calorie Restriction and Diet-Induced Obesity on Murine Colon Carcinogenesis, Growth and Inflammatory Factors, and MicroRNA Expression
por: Olivo-Marston, Susan E., et al.
Publicado: (2014)

Sarcomatoid carcinoma of colon: extremely poor prognosis
por: Choi, Yoon Young, et al.
Publicado: (2011)

Circulating precursors of human CD1c(+) and CD141(+) dendritic cells
por: Breton, Gaëlle, et al.
Publicado: (2015)

Downregulation of Activin A Receptor Type 2A Is Associated with Metastatic Potential and Poor Prognosis of Colon Cancer
por: Zhuo, Changhua, et al.
Publicado: (2018)

MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma
por: Zhao, Zhiguo, et al.
Publicado: (2019)

A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng
por: Poudyal, Deepak, et al.
Publicado: (2013)

miR-183 and miR-141 in lesion tissues are potential risk factors for poor prognosis in patients with infected abdominal aortic aneurysm
por: Meng, Chunying, et al.
Publicado: (2018)

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
por: Bulfoni, Michela, et al.
Publicado: (2016)

miR-141 promotes colon cancer cell proliferation by inhibiting MAP2K4
por: Ding, Lei, et al.
Publicado: (2017)

miR-141 Promotes Colon Cancer Cell Proliferation by Targeted PHLPP2 Expression Inhibitionn
por: Fang, Fazhuang, et al.
Publicado: (2020)

Renal Cell Carcinoma with Right Ventricular Metastatic Spread: An Unusual Finding with Poor Prognosis
por: Richardson, Aaron, et al.
Publicado: (2020)

Circulating acetoacetate is associated with poor prognosis in heart failure patients()
por: Yokokawa, Tetsuro, et al.
Publicado: (2019)

Brain enhancer activities at the gene-poor 5p14.1 autism-associated locus
por: Inoue, Yukiko U., et al.
Publicado: (2016)

Management of metastatic renal cell carcinoma in patients with poor prognosis
por: Bullock, Andrea, et al.
Publicado: (2010)

Clinical characteristics and prognosis of 196 Chinese patients with colon cancer
por: Yao, Lunjin, et al.
Publicado: (2023)

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
por: Antolín, Silvia, et al.
Publicado: (2015)

Abnormally high HIP1 expression is associated with metastatic behaviors and poor prognosis in ESCC
por: Sun, Ying, et al.
Publicado: (2021)

Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer
por: Li, Man, et al.
Publicado: (2014)

The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest
por: Cui, Xiangli, et al.
Publicado: (2013)

Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
por: Ou, Guoping, et al.
Publicado: (2019)

141st LHCC Meeting
Publicado: (2020)

141st SPSC Meeting
Publicado: (2021)

141. Impact of Diagnostic Stewardship of Respiratory Cultures in the Pediatric ICU
por: Hamilton, Christine D, et al.
Publicado: (2023)

Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer
por: Yang, Bo, et al.
Publicado: (2014)

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022)

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma
por: Zhan, Weixiang, et al.
Publicado: (2023)

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
por: Wu, Moxin, et al.
Publicado: (2020)

GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2022)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_48vkj1e8rsl5klnqvl7gsugkc6